Biotech · Private company
Altavant Sciences GmbH
Track this companyFree. Adds Altavant Sciences GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- rodatristat ethyl 300 mg tablet BIDPhase 2 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- rodatristat ethyl 600 mg BIDPhase 2 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- RVT-1201Phase 2 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- MoxifloxacinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Radio-labeled rodatristat ethyl 600 mgPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Rodatristat EthylPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Rodatristat Ethyl 300 mg BIDPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Rodatristat Ethyl 600 mg BIDPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the HeartPHASE1 · COMPLETED · started May 12, 2023ClinicalTrials.gov NCT05933447 · fetched Nov 12, 2026
- A Single and Multiple Dose of Rodatristat Ethyl in Healthy Adult Subjects to Evaluate the Effect of Food and SafetyPHASE1 · COMPLETED · started Sep 29, 2022ClinicalTrials.gov NCT05684640 · fetched Nov 12, 2026
- Multiple-Ascending Dose in Japanese Patients Bridging StudyPHASE1 · COMPLETED · started Oct 1, 2021ClinicalTrials.gov NCT05065359 · fetched Nov 12, 2026
- Pharmacokinetics and Excretion of Oral [14C]-Rodatristat EthylPHASE1 · COMPLETED · started Sep 23, 2021ClinicalTrials.gov NCT05006118 · fetched Nov 12, 2026
- A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)PHASE2 · COMPLETED · started Mar 15, 2021ClinicalTrials.gov NCT04712669 · fetched Nov 12, 2026
- A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)PHASE2 · TERMINATED · started Aug 1, 2019ClinicalTrials.gov NCT03924154 · fetched Nov 12, 2026